Matt Dellatorre

Stock Analyst at Goldman Sachs

(2.47)

# 3,059

Out of 5,182 analysts

5

Total ratings

75%

Success rate

16.47%

Average return

Main Sectors:

Top Industries:

Drug Manufacturers - Specialty & Generic

Stocks Rated by Matt Dellatorre

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	TEVA Teva Pharmaceutical Industries	Maintains: Buy	$36 → $45	$31.15	+44.46%	4	Feb 9, 2026
	VTRS Viatris	Initiates: Neutral	$10	$13.83	-27.69%	1	Jun 6, 2025

Teva Pharmaceutical Industries

Feb 9, 2026

Maintains: Buy

Price Target: $36 → $45

Current: $31.15

Upside: +44.46%

Viatris

Jun 6, 2025

Initiates: Neutral

Price Target: $10

Current: $13.83

Upside: -27.69%